Stockreport

UroGen Pharma Reports First Quarter 2021 Financial Results and Recent Corporate Developments

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF Jelmyto® net product revenue of $7.5 million for the first quarter of 2021New patient starts in March and April of 2021 increased 100% and 165%, respectively, compared t [Read more]